Not applicableStudy completedNCT00423553What this trial is testingCollection of Heart Tissue Sample During Open Heart SurgeryWho this might be right forIschemia National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT00003068What this trial is testingHigh-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerWho this might be right forBreast CancerDrug/Agent Toxicity by Tissue/Organ University of Arizona 30
Testing effectiveness (Phase 2)WithdrawnNCT04843722What this trial is testingCOVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based VaccinesWho this might be right forCovid19 ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT06967025What this trial is testingIschemic Postconditioning in Acute Stroke Patients Receiving Endovascular ThrombectomyWho this might be right forStroke AcuteCytoprotectionIschemic Conditioning Tianjin Huanhu Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00003425What this trial is testingPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectWho this might be right forBreast CancerLeukemiaLymphoma+4 more University of Kentucky 25
Testing effectiveness (Phase 2)WithdrawnNCT04845191What this trial is testingCOVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based VaccinesWho this might be right forCovid19 ImmunityBio, Inc.
Large-scale testing (Phase 3)UnknownNCT05885919What this trial is testingEffect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic StrokeWho this might be right forIschemic Stroke, AcuteTreatment Outcome Xiangya Hospital of Central South University 212
Testing effectiveness (Phase 2)WithdrawnNCT00556387What this trial is testingEfficacy of Ketamine in Children With Severe Brain Injury for Brain Cell ProtectionWho this might be right forTraumatic Brain Injury University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT00006105What this trial is testingGemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerWho this might be right forBladder CancerDrug/Agent Toxicity by Tissue/Organ University of Chicago 37
Early research (Phase 1)Study completedNCT00482846What this trial is testingMelphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple MyelomaWho this might be right forMucositisMultiple Myeloma Barbara Ann Karmanos Cancer Institute 38
Testing effectiveness (Phase 2)Looking for participantsNCT06440707What this trial is testingTranscranial Direct Current Stimulation for Treatment of Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke University of California, Los Angeles 120
Testing effectiveness (Phase 2)Study completedNCT00623142What this trial is testingThe Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart SurgeryWho this might be right forMyocardial Reperfusion InjuryCytoprotection Hull University Teaching Hospitals NHS Trust 81
Not applicableActive Not RecruitingNCT07174882What this trial is testingEvaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa ResistanceWho this might be right forNon-Erosive Gastro-Esophageal Reflux DiseaseGastroesophageal Reflux Disease (GERD) I.M. Sechenov First Moscow State Medical University 60
Early research (Phase 1)Study completedNCT00571298What this trial is testingExtrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Brigham and Women's Hospital 141